bausch health companies inc glp-1 receptor agonist medications Adjunctive GLP1 Agonists in Patients With Inflammatory Bowel Diseases and Obesity and/or Diabetes: A Target Trial Emulation Glucagon-like peptide-1 receptor agonists (GLP-1RAs)

These findings are robust and supported by various predefined sensitivity tests and external data validation

M.H.A.M

Instead of focusing only on calorie restriction, modern research increasingly explores: Hormonal appetite regulation Gut-brain signalling Insulin sensitivity Energy expenditure Body composition Cardiometabolic risk markers This is why Retatrutide is often mentioned in the same conversation as GLP-1 receptor agonists, GIP/GLP-1 dual agonists, and other next-generation metabolic peptides

10.1007/BF00401145 7

And so it is important that these medications are prescribed in the setting of a comprehensive weight management program so that patients can do the other parts of healthy weight management to maintain their health and their muscle mass

Do not use GLP-1 medications if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)